Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer

NCT02048943 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Duct Cell Adenocarcinoma of the Pancreas
Recurrent Pancreatic Cancer
Stage III Pancreatic Cancer
Stage IV Pancreatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: dovitinib lactate
DRUG: gemcitabine hydrochloride
DRUG: paclitaxel albumin-stabilized nanoparticle formulation
OTHER: pharmacological study
OTHER: laboratory biomarker analysis

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]
[object Object]